Aaron R Weiss

14PUBLICATIONS
69CO-AUTHORS
Medical mycologyMolecular targetsPredictive and prognostic markersRadiation therapySolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 24, 2026
Omitting Bone Marrow Sampling in FDG-Avid Rhabdomyosarcoma With 2-[18F]FDG PET-Negative Marrow: Results From an International Retrospective Study.

|Jun 28, 2024
Roadmap for the next generation of Children's Oncology Group rhabdomyosarcoma trials.

Jonathan L Metts, Jamie M Aye, Jacquelyn N Crane

|May 17, 2024
Clinical features and outcomes of young patients with low-grade non-rhabdomyosarcoma soft tissue sarcomas treated with a risk-based strategy: A report from Children's Oncology Group study ARST0332.

David P Douglass, Cheryl M Coffin, R Lor Randall

|Apr 17, 2024
Event-free survival in relapsed and refractory rhabdomyosarcoma treated on cooperative group phase II trials: A report from the Children's Oncology Group.

Jonathan Metts, Wei Xue, Zhengya Gao

|Apr 03, 2024
Embryonal sarcoma of the liver in pediatric and young adult patients: A report from Children's Oncology Group study ARST0332.

Sheri L Spunt, Wei Xue, Zhengya Gao

|Mar 12, 2024
Outcome of patients with relapsed or refractory nonrhabdomyosarcoma soft tissue sarcomas enrolled in phase 2 cooperative group clinical trials: A report from the Children's Oncology Group.

Sapna Oberoi, Amira Qumseya, Wei Xue

Pageof 3

Frequent Collaborators

3 joint publications

Sapna Oberoi

3 joint publications

Sheri L Spunt

2 joint publications

David P Douglass

2 joint publications

Douglas S Hawkins